These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29055565)

  • 1. Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy.
    Gutierrez-Franco J; Hernandez-Gutierrez R; Bueno-Topete MR; Haramati J; Navarro-Hernandez RE; Escarra-Senmarti M; Vega-Magaña N; Del Toro-Arreola A; Pereira-Suarez AL; Del Toro-Arreola S
    Immunobiology; 2018 Jan; 223(1):57-63. PubMed ID: 29055565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.
    Bjørnsen EG; Thiruchelvam-Kyle L; Hoelsbrekken SE; Henden C; Saether PC; Boysen P; Daws MR; Dissen E
    Eur J Immunol; 2019 Jan; 49(1):54-65. PubMed ID: 30512185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells.
    Phillips M; Romeo F; Bitsaktsis C; Sabatino D
    Biopolymers; 2016 Sep; 106(5):658-72. PubMed ID: 27216712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients.
    Gutierrez-Silerio GY; Bueno-Topete MR; Vega-Magaña AN; Bastidas-Ramirez BE; Gutierrez-Franco J; Escarra-Senmarti M; Pedraza-Brindis EJ; Peña-Rodriguez M; Ramos-Marquez ME; Delgado-Rizo V; Banu N; Alejandre-Gonzalez AG; Fafutis-Morris M; Haramati J; Del Toro-Arreola S
    Immunology; 2023 Mar; 168(3):538-553. PubMed ID: 36271832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6.
    Hua CK; Gacerez AT; Sentman CL; Ackerman ME
    Protein Eng Des Sel; 2017 Oct; 30(10):713-721. PubMed ID: 29040754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
    Schlecker E; Fiegler N; Arnold A; Altevogt P; Rose-John S; Moldenhauer G; Sucker A; Paschen A; von Strandmann EP; Textor S; Cerwenka A
    Cancer Res; 2014 Jul; 74(13):3429-40. PubMed ID: 24780758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.
    Butler SE; Brog RA; Chang CH; Sentman CL; Huang YH; Ackerman ME
    Cancer Immunol Immunother; 2022 Jan; 71(1):165-176. PubMed ID: 34046711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
    Kilian M; Friedrich MJ; Lu KH; Vonhören D; Jansky S; Michel J; Keib A; Stange S; Hackert N; Kehl N; Hahn M; Habel A; Jung S; Jähne K; Sahm F; Betge J; Cerwenka A; Westermann F; Dreger P; Raab MS; Meindl-Beinker NM; Ebert M; Bunse L; Müller-Tidow C; Schmitt M; Platten M
    Sci Immunol; 2024 May; 9(95):eadj7970. PubMed ID: 38701193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.
    Flajnik MF; Tlapakova T; Criscitiello MF; Krylov V; Ohta Y
    Immunogenetics; 2012 Aug; 64(8):571-90. PubMed ID: 22488247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrated stress response promotes B7H6 expression.
    Obiedat A; Charpak-Amikam Y; Tai-Schmiedel J; Seidel E; Mahameed M; Avril T; Stern-Ginossar N; Springuel L; Bolsée J; Gilham DE; Dipta P; Shmuel M; Chevet E; Mandelboim O; Tirosh B
    J Mol Med (Berl); 2020 Jan; 98(1):135-148. PubMed ID: 31838577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
    Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
    Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
    Pekar L; Klausz K; Busch M; Valldorf B; Kolmar H; Wesch D; Oberg HH; Krohn S; Boje AS; Gehlert CL; Toleikis L; Krah S; Gupta T; Rabinovich B; Zielonka S; Peipp M
    J Immunol; 2021 Jan; 206(1):225-236. PubMed ID: 33268483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity.
    Wu MR; Zhang T; DeMars LR; Sentman CL
    Gene Ther; 2015 Aug; 22(8):675-84. PubMed ID: 25830550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates.
    Ohta Y; Flajnik MF
    Immunol Rev; 2015 Sep; 267(1):6-15. PubMed ID: 26284468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
    Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
    J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
    Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research Advances of A New Co-stimulatory Molecule-B7 Homolog 6--Review].
    Wu FF; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):295-8. PubMed ID: 26913440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer.
    Zhu Z; Teng KY; Zhou J; Xu Y; Zhang L; Zhao H; Zhang X; Tian L; Li Z; Lu T; Ma S; Li Z; Dai Z; Wang J; Chen X; Wu X; Pan Y; Shi W; You Z; Chen H; Chung V; Yu J; He S; Zhao X; Cao L; Li D
    Front Oncol; 2022; 12():814312. PubMed ID: 35311080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
    Semeraro M; Rusakiewicz S; Minard-Colin V; Delahaye NF; Enot D; Vély F; Marabelle A; Papoular B; Piperoglou C; Ponzoni M; Perri P; Tchirkov A; Matta J; Lapierre V; Shekarian T; Valsesia-Wittmann S; Commo F; Prada N; Poirier-Colame V; Bressac B; Cotteret S; Brugieres L; Farace F; Chaput N; Kroemer G; Valteau-Couanet D; Zitvogel L
    Sci Transl Med; 2015 Apr; 7(283):283ra55. PubMed ID: 25877893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.